OBJECTIVES: The treatment of persistent and long-standing persistent atrial fibrillation (AF) has unsatisfactory results using both medical therapy and/or catheter ablation, where incomplete ablation lines remain a significant problem. This study evaluates the feasibility, efficacy and safety of the sequential, two-staged hybrid treatment combining thoracoscopic surgical and transvenous catheter AF ablation. METHODS: Thirty patients with persistent and long-standing persistent AF underwent surgical thoracoscopic radiofrequency (RF) ablation procedure using a predefined protocol (pulmonary veins isolation, box lesion, isthmus line lesion, dissection of the ligament of Marshall, left atrial appendage exclusion with an epicardial clip and ganglionated plexi ablation) followed by diagnostic catheterization and RF ablation 3 months later. In this session, electrical mapping of the left atrium was performed and any incomplete isolation lines were completed. Mitral and cavotricuspid isthmus ablation lines were performed during this session as well. RESULTS: The preoperative mean duration time of AF was 33 ± 27 months with 17% patients with persistent and 83% patients with long-standing persistent AF. The mean size of the left atrium was 48 ± 5 mm. The complete surgical ablation protocol was achieved in 97% of patients, with no death, and no early stroke or pacemaker implantation in the early postoperative period. In 63% of patients, the left atrial appendage was excluded with an epicardial clip. An endocardial touch-up for achievement of bidirectional block of pulmonary veins was necessary in 10 patients (33%) and on the box, (roof and floor) lesions in 20 patients (67%). Freedom from atrial fibrillation was 77% after surgical ablation and 93% after the completed hybrid procedure. CONCLUSIONS: The sequential, two-staged hybrid strategy (surgical thoracoscopic followed by catheter ablation) is feasible and safe with a high post-procedural success and seems to represent the optimal treatment with low risk load and potentially long-term benefit for patients with a persistent and long-standing persistent form atrial fibrillation.

Department of Cardiac Surgery Hospital České Budějovice České Budějovice Czech Republic

Komentář v

Interact Cardiovasc Thorac Surg. 2014 Apr;18(4):456. doi: 10.1093/icvts/ivu057. PubMed

Zobrazit více v PubMed

Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110:1042–6. PubMed

Benjamin EJ, Wolf PA, D´Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946–52. PubMed

Marcus GM, Sung RJ. Antiarrhythmic agents in facilitating electrical cardioversion of atrial fibrillation and promoting maintenance of sinus rhythm. Cardiology. 2001;95:1–8. PubMed

Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial designs (A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Hearth Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, The American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society) Heart Rhythm. 2012;9:632–96. PubMed

Fiala M, Skňouřil L, Toman O, Pindor J, Bulková V, Chovančík J, et al. Long-term results of catheter ablation for atrial fibrillation in 866 patients. Cor et Vasa. 2012;54:e361–8.

Weerasooriya R, Khairy P, Litalien J, Macle L, Hocini M, Sacher F, et al. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol. 2011;57:160–6. PubMed

Cheema A, Chandrasekhar R, Vasamreddy CR, Dalal D, Marine JE, Dong J, et al. Long-term single procedure efficacy of catheter ablation of atrial fibrillation. J Interv Card Electrophysiol. 2006;15:145–55. PubMed

Lo LW, Tai CT, Lin YJ, Chang SL, Udyavar AR, Hu YF, et al. Predicting factors for atrial fibrillation acute termination during catheter ablation procedures: implications for catheter ablation strategy and long-term outcome. Heart Rhythm. 2009;6:311–8. PubMed

Boersma LV, Castella M, van Boven W, Berruezo A, Yilmaz A, Nadal M, et al. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation. 2012;125:23–30. PubMed

Castellá M, García-Valentin A, Pereda D, Colli A, Martinez A, Martinez D, et al. Anatomic aspects of the atrioventricular junction influencing radiophrequency Cox maze IV procedures. J Thorac Cardiovasc Surg. 2008;136:419–23. PubMed

Gaynor SL, Diodato MD, Prasad SM, Ishii Y, Schuessler RB, Bailey MS, et al. A prospective, single-center clinical trial of a modified Cox Maze procedure with bipolar radiofrequency ablation. J Thorac Cardiovasc Surg. 2004;128:535–42. PubMed

Melby SJ, Gaynor SL, Lubahn JG, Lee AM, Rahgozar P, Caruthers SD, et al. Efficacy and safety of right and left atrial ablations on the beating heart with irrigated bipolar radiofrequency energy: a long-term animal study. J Thorac Cardiovasc Surg. 2006;132:853–60. PubMed

Cappato R, Negroni S, Pecora D, Bentivegna S, Lupo PP, Carolei A, et al. Prospective assessment of late conduction recurrence across radiofrequency lesions producing electrical disconnection at the pulmonary vein ostium in patients with atrial fibrillation. Circulation. 2003;108:1599–604. PubMed

Wolf RK, Schneeberger EW, Osterday R, Miller D, Merrill W, Flege JB, et al. Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. J Thorac Cardiovasc Surg. 2005;130:797–802. PubMed

Bage L, Blomstrom P, Nilsson L, Einarsson GM, Jedéus L, Blomstrom-Lundqvist C. Epicardial off-pump pulmonary vein isolation and vagal denervation improve long-term outcome and quality of life in patients with atrial fibrillation. J Thorac Cardiovasc Surg. 2008;137:1265–71. PubMed

Puskas J, Lin E, Bailey D, Gyuton R. Thoracoscopic radiofrequency pulmonary vein isolation and atrial appendage occlusion. Ann Thorac Surg. 2007;83:1870–2. PubMed

Shirak J, Schwartzman D. Interim results of the 5-box thoracoscopic maze procedure. Ann Thorac Surg. 2012;94:1880–5. PubMed

Yilmaz A, Geuzebroek GS, Van Putte BP, Boersma LVA, Sonker U, De Bakker JMT, et al. Completely thoracoscopic pulmonary vein isolation with ganglionic plexus ablation and left atrial appendage amputation for treatment of atrial fibrillation. Eur J Cardiothorac Surg. 2010;38:356–60. PubMed

Schauerte P, Scherlag BJ, Patterson E, Scherlag MD, Matsudaria K, Nakagawa H, et al. Focal atrial fibrillation: experimental evidence for pathophysiologic role of the autonomic nervous system. J Cardiovasc Electrophysiol. 2001;12:592–9. PubMed

Weimar T, Vosseler M, Czelsa M, Boscheinen M, Hemmer WB, Doll KN. Approaching a paradigm shift: endoscopic ablation of lone atrial fibrillation on the beating heart. Ann Thorac Surg. 2012;94:1886–93. PubMed

Pison L, La Meir M, van Opstal J, Blaauw Y, Maessen J, Crijins HJ. Hybrid thoracoscopic surgical and transvenous catheter ablation of atrial fibrillation. JACC. 2012;60:54–61. PubMed

Kolář P. Rehabilitation in Clinical Praxis. Prague: Galén; 2011. pp. 572–6.

European multicentre experience of staged hybrid atrial fibrillation ablation for the treatment of persistent and longstanding persistent atrial fibrillation

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

Midterm outcomes of two-staged hybrid ablation of persistent and long-standing persistent atrial fibrillation using the versapolar epicardial surgical device and subsequent catheter ablation

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

Sequential Hybrid CryoMaze Ablation versus Surgical CryoMaze Alone for the Treatment of Atrial Fibrillation (SurHyb): study protocol for a randomized controlled trial

Sequential hybrid procedure for persistent atrial fibrillation